Stuart Snyder

Array ( [id] => 5514284 [patent_doc_number] => 20090214590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Virus Vaccines Comprising Envelope-Bound Immunomodulatory Proteins and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/988358 [patent_app_country] => US [patent_app_date] => 2006-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21986 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214590.pdf [firstpage_image] =>[orig_patent_app_number] => 11988358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219767 [patent_doc_number] => 20070161078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Methods and compositions for diagnosis and treatment of influenza' [patent_app_type] => utility [patent_app_number] => 11/481411 [patent_app_country] => US [patent_app_date] => 2006-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 56788 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161078.pdf [firstpage_image] =>[orig_patent_app_number] => 11481411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5601822 [patent_doc_number] => 20060292167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Therapeutic Peptides and Vaccines' [patent_app_type] => utility [patent_app_number] => 11/426301 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9575 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292167.pdf [firstpage_image] =>[orig_patent_app_number] => 11426301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9868848 [patent_doc_number] => 08956617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-17 [patent_title] => 'Vaccination by transcutaneous targeting' [patent_app_type] => utility [patent_app_number] => 11/993737 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 22 [patent_no_of_words] => 8720 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11993737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6420235 [patent_doc_number] => 20100150923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'FUSION PROTEINS OF RECOMBINANT SARS CORONAVIRUS STRUCTURAL PROTEINS, THEIR PRODUCTION AND USES' [patent_app_type] => utility [patent_app_number] => 11/993176 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 14106 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150923.pdf [firstpage_image] =>[orig_patent_app_number] => 11993176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552237 [patent_doc_number] => 20090286223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Methods And Kits For In Situ Measurement of Enzyme Activity and Amount Using Single Measurement System' [patent_app_type] => utility [patent_app_number] => 12/302418 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5506 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286223.pdf [firstpage_image] =>[orig_patent_app_number] => 12302418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4704501 [patent_doc_number] => 20080064025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Cooperative reporter systems, components, and methods for analyte detection' [patent_app_type] => utility [patent_app_number] => 11/440215 [patent_app_country] => US [patent_app_date] => 2006-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9563 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064025.pdf [firstpage_image] =>[orig_patent_app_number] => 11440215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922142 [patent_doc_number] => 20060240414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Genetically engineered glutaminase and its use in antiviral and anticancer therapy' [patent_app_type] => utility [patent_app_number] => 11/416133 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7801 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240414.pdf [firstpage_image] =>[orig_patent_app_number] => 11416133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5557788 [patent_doc_number] => 20090269365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'IMMUNOGENIC VACCINIA PEPTIDES AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 11/911706 [patent_app_country] => US [patent_app_date] => 2006-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19882 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269365.pdf [firstpage_image] =>[orig_patent_app_number] => 11911706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5753511 [patent_doc_number] => 20060222660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Use of DNA vaccine in combination with a conventional vaccine to overcome immunogen interference' [patent_app_type] => utility [patent_app_number] => 11/390715 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1812 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20060222660.pdf [firstpage_image] =>[orig_patent_app_number] => 11390715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53154 [patent_doc_number] => 07767209 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'Modified vaccinia virus Ankara (MVA) mutant and use thereof' [patent_app_type] => utility [patent_app_number] => 11/375159 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11443 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767209.pdf [firstpage_image] =>[orig_patent_app_number] => 11375159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688255 [patent_doc_number] => 20060286570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Use of photopolymerization for amplification and detection of a molecular recognition event' [patent_app_type] => utility [patent_app_number] => 11/372485 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12121 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286570.pdf [firstpage_image] =>[orig_patent_app_number] => 11372485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 266930 [patent_doc_number] => 07566454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => 'Influenza nucleic acids, polypeptides, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/362617 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 38 [patent_no_of_words] => 17183 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566454.pdf [firstpage_image] =>[orig_patent_app_number] => 11362617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314541 [patent_doc_number] => 07524510 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Alkyl-glycoside enhanced vaccination' [patent_app_type] => utility [patent_app_number] => 11/360761 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9536 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524510.pdf [firstpage_image] =>[orig_patent_app_number] => 11360761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9299593 [patent_doc_number] => 08647818 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-11 [patent_title] => 'Molecular scaffolds for HIV-1 immunogens' [patent_app_type] => utility [patent_app_number] => 11/816624 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12821 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11816624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886443 [patent_doc_number] => 20080260775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'New Live Virus Vaccines' [patent_app_type] => utility [patent_app_number] => 11/816360 [patent_app_country] => US [patent_app_date] => 2006-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 23298 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260775.pdf [firstpage_image] =>[orig_patent_app_number] => 11816360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879290 [patent_doc_number] => 20080152673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Desiccated Product' [patent_app_type] => utility [patent_app_number] => 11/815947 [patent_app_country] => US [patent_app_date] => 2006-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5385 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152673.pdf [firstpage_image] =>[orig_patent_app_number] => 11815947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 891458 [patent_doc_number] => 07344830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Heteroduplex tracking assay' [patent_app_type] => utility [patent_app_number] => 11/333073 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 27921 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/344/07344830.pdf [firstpage_image] =>[orig_patent_app_number] => 11333073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307300 [patent_doc_number] => 07531366 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Bead based assays using a liquid crystal reporter' [patent_app_type] => utility [patent_app_number] => 11/328040 [patent_app_country] => US [patent_app_date] => 2006-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27950 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531366.pdf [firstpage_image] =>[orig_patent_app_number] => 11328040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4994576 [patent_doc_number] => 20070009921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Fragments of virus protein 2 or 3 of polyoma virus as vehicles for active substances' [patent_app_type] => utility [patent_app_number] => 11/316467 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2984 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009921.pdf [firstpage_image] =>[orig_patent_app_number] => 11316467 [rel_patent_id] =>[rel_patent_doc_number] =>)